1. Home
  2. LGCB vs CING Comparison

LGCB vs CING Comparison

Compare LGCB & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGCB
  • CING
  • Stock Information
  • Founded
  • LGCB 2011
  • CING 2012
  • Country
  • LGCB Japan
  • CING United States
  • Employees
  • LGCB N/A
  • CING N/A
  • Industry
  • LGCB
  • CING Biotechnology: Pharmaceutical Preparations
  • Sector
  • LGCB
  • CING Health Care
  • Exchange
  • LGCB Nasdaq
  • CING Nasdaq
  • Market Cap
  • LGCB 14.8M
  • CING 17.3M
  • IPO Year
  • LGCB 2023
  • CING 2021
  • Fundamental
  • Price
  • LGCB $2.45
  • CING $4.35
  • Analyst Decision
  • LGCB
  • CING Strong Buy
  • Analyst Count
  • LGCB 0
  • CING 4
  • Target Price
  • LGCB N/A
  • CING $30.67
  • AVG Volume (30 Days)
  • LGCB 7.7K
  • CING 94.1K
  • Earning Date
  • LGCB 07-03-2025
  • CING 08-12-2025
  • Dividend Yield
  • LGCB N/A
  • CING N/A
  • EPS Growth
  • LGCB N/A
  • CING N/A
  • EPS
  • LGCB N/A
  • CING N/A
  • Revenue
  • LGCB $10,289,681.00
  • CING N/A
  • Revenue This Year
  • LGCB N/A
  • CING N/A
  • Revenue Next Year
  • LGCB N/A
  • CING N/A
  • P/E Ratio
  • LGCB N/A
  • CING N/A
  • Revenue Growth
  • LGCB N/A
  • CING N/A
  • 52 Week Low
  • LGCB $1.22
  • CING $1.80
  • 52 Week High
  • LGCB $57.05
  • CING $20.83
  • Technical
  • Relative Strength Index (RSI)
  • LGCB 55.85
  • CING 55.28
  • Support Level
  • LGCB $2.25
  • CING $4.26
  • Resistance Level
  • LGCB $2.54
  • CING $4.69
  • Average True Range (ATR)
  • LGCB 0.13
  • CING 0.22
  • MACD
  • LGCB 0.00
  • CING 0.02
  • Stochastic Oscillator
  • LGCB 71.43
  • CING 64.56

About LGCB Linkage Global Inc

Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Share on Social Networks: